Accelerate Your Therapeutic Success with Expert Nonclinical Safety Consulting
From discovery to the clinic, Toxistrategy delivers tailored nonclinical safety solutions to meet your program's unique challenges. Whether navigating toxicology strategy, IND-enabling packages or regulatory authoring, we provide unmatched
expertise to ensure your therapeutic reaches its full potential.
SERVICES
Nonclinical Safety + Toxicology
Nonclinical development of assets from discovery to clinic, including overall toxicology strategy, study execution, management, and reporting.
Regulatory Oversight
Strategic planning, timeline coordination and authoring of regulatory documents, including INDs, CTAs, IBs, BBs, and more.
SEND Datasets
Oversight of SEND datasets including dataset requirements, review and submission.
WHO WE ARE
Dessi McEntee, MS, DABT
Owner & Consultant
Dessi is a board-certified toxicologist whose unique combination of expertise puts her in the top 1% of nonclinical safety professionals in the industry. She has amassed over a decade of extensive experience in the exploratory and GLP nonclinical sciences of the pharmaceutical and biotech industries, and has championed the advancement of numerous critical medicines to the clinic through successful leadership of Toxicology, Safety Pharmacology and DART strategies related to both small and large molecule therapeutics. Dessi has been the toxicologist at numerous different startups and is batting a thousand in regulatory submissions.
Toxistrategy is a one-woman operation. Instead of a team of consultants trying to stretch the hours for more money, you get a personalized, high touch consultant who will not only meet your expectations but exceed them. I will make your breakthrough a reality.